Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wintsch

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1986
Effects of bopindolol on renal functionJ Fabre, J Wintsch, R Peter-Contesse, et al.
AIDS (London, England)|December 1, 1990
Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug usersE Chamot, B Hirschel, J Wintsch, et al.
AIDS (London, England)|July 1, 1990
Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980-1989C F Robert, J J Déglon, J Wintsch, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1990
Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope proteinS Abrignani, D Montagna, M Jeannet, et al.
The Journal of Infectious Diseases|February 1, 1991
Safety and immunogenicity of a genetically engineered human immunodeficiency virus vaccineJ Wintsch, C L Chaignat, D G Braun, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Cardiovascular Pharmacology|January 1, 1986
Effects of bopindolol on renal functionJ Fabre, J Wintsch, R Peter-Contesse, et al.
AIDS (London, England)|December 1, 1990
Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug usersE Chamot, B Hirschel, J Wintsch, et al.
AIDS (London, England)|July 1, 1990
Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980-1989C F Robert, J J Déglon, J Wintsch, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1990
Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope proteinS Abrignani, D Montagna, M Jeannet, et al.
The Journal of Infectious Diseases|February 1, 1991
Safety and immunogenicity of a genetically engineered human immunodeficiency virus vaccineJ Wintsch, C L Chaignat, D G Braun, et al.
Pageof 1